Chromogranin A is an aging risk factor
嗜铬粒蛋白 A 是衰老的危险因素
基本信息
- 批准号:10667265
- 负责人:
- 金额:$ 22.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-15 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:Adipose tissueAdrenergic ReceptorAgeAgingAlzheimer&aposs disease brainAlzheimer&aposs disease patientAnti-Inflammatory AgentsAntidiabetic DrugsAntihypertensive AgentsAntioxidantsAutoimmune DiseasesAutophagocytosisBacterial DNABiochemicalBiological ProcessBloodBlood GlucoseBlood PressureBlood VesselsCardiacCatecholaminesCellsCessation of lifeCharacteristicsCholesterolChromogranin AChronicClinicalCollaborationsCommunicationCoupledDataDense Core VesicleDevelopmentDiabetes MellitusDiseaseEatingElderlyEndocrineEnergy MetabolismExhibitsExtravasationFatty AcidsFemaleFutureGene ExpressionGene Expression ProfilingGenesGoalsGrowthHealthHeartHeart failureHormonesHypertensionImmunoglobulin DomainInfectionInflammationInflammatoryInflammatory Bowel DiseasesInflammatory ResponseInsulinInsulin ResistanceIntestinal permeabilityKidney FailureKnock-outKnockout MiceLifeLipoproteinsLiverLiver DysfunctionLongevityLongitudinal StudiesMaintenanceMalignant NeoplasmsMediatingMessenger RNAMetabolismMitochondriaModelingMusMuscleNeuroendocrine CellNeuronsNeurosecretory SystemsNeurotransmittersNorepinephrineOrganPathogenicityPathway interactionsPatientsPeptidesPhysiologicalPhysiologyPlasmaProcessProteinsProteolytic ProcessingPublishingRegulationReportingResearchRespirationRheumatoid ArthritisRisk FactorsRoleSET DomainSignal PathwaySignal TransductionTestingTissue SampleTissuesTranscriptTriglyceridesTumor Suppressor ProteinsWild Type Mouseadipokinesadiponectinage groupage relatedagedblood pressure elevationcohortdiabeticexperimental studyhuman old age (65+)hypertensiveimprovedinsulin sensitivitylipid metabolismlipoprotein lipasemalemature animalmouse modelnervous system disorderoverexpressionpancreastatinpeptide hormoneprohormoneresistance genetargeted treatmenttranscriptome sequencing
项目摘要
PROJECT SUMMARY
Chromogranin A (CgA) is a component of dense core vesicles of endocrine and neuroendocrine cells and
neurons that control the storage of neurotransmitters and hormones. CgA is a prohormone which is
processed into peptide hormones with distinct biological functions. Two of these peptides, catestatin (CST:
hCgA352-372) and pancreastatin (PST: hCgA250-301), exhibit diametrically opposite functions: CST is anti-
hypertensive, anti-inflammatory, and anti-diabetic, whereas PST is pro-inflammatory, pro-hypertensive and
pro-diabetic. High levels of CgA are present in the blood of patients with malignancies, inflammatory
diseases, and neurological disorders, and their levels rise as their clinical conditions worsen. Although Chga
(gene encoding CgA)-null mice have been available for nearly 20 years and have been widely studied, the
impact of CgA on aging has not been investigated. We found that CgA-KO mice develop hypertension at a
young age, but it reverses beyond the age of 12 months. We also noted that a few unused CgA-KO mice (all
male) that were kept aside lived at least 40 months. We also found that mRNA levels of lipoprotein lipase
(LPL), which controls triglyceride levels and V-set and immunoglobulin domain containing 4 (Vsig4), which
control bacterial clearance via autophagy, are low in the heart and liver of CgA-KO young mice but high in
old mice. We further found that leakage of bacterial DNA to other different organs in older WT mice. These
preliminary observations imply that CgA is an aging-inducing factor, but it has a positive role at early
ages through maintenance of lipid metabolism. We propose that differential processing of CgA into CST
and PST would determine aging through regulation of factors involved in metabolism and inflammation. This
proposal aims to investigate the validity of our hypothesis by assessing the lifespan, growth, mitochondrial
health, energy expenditure of a larger cohort of WT and CgA-KO males and females. We will further
determine the factors critical for CgA-induced aging and the pathways involved in the spontaneous reversal
of hypertension and lifespan extension of CgA-KO mice with emphasis on the lipoprotein-adipokine,
catecholamine-adrenergic receptor and Vsig-4-autophagy signaling axes in four different tissues.
The proposed research will be led by two Co-PIs: Dr. Mahata, a physiologist whose research focuses
on hypertension, insulin resistance and immunometabolism, and Dr. Ghosh, a biochemist who studies
inflammatory responses through the IKK-NF-B signaling pathways. If the hypotheses prove to be correct,
long-term studies to determine the underlying mechanisms of CgA-induced aging will be conducted.
Experiments proposed here will also help to determine if CgA can be targeted for therapy against
inflammatory disorders, aging-related and neurological disorders by lowering CgA transcripts at an older age
to reduce the pathogenic repercussions.
项目摘要
促炎A(CGA)是内分泌和神经内分泌细胞的密集核心蔬菜的组成部分
控制神经递质和激素的存储的神经元。 CGA是一种激素
加工成具有不同生物学功能的肽恐怖。这些肽中的两个是catestatin(CST:
HCGA352-372)和胰腺蛋白(PST:HCGA250-301),暴露于直径相反的功能:CST是抗
高血压,抗炎和抗糖尿病患者,而PST具有促炎,促疾病
亲糖尿病。恶性,炎症患者的血液中存在高水平的CGA
疾病和神经系统疾病及其水平随临床状况恶化而升高。虽然cha
(编码CGA的基因) - 无小鼠已有近20年的时间,并且已被广泛研究,
尚未研究CGA对衰老的影响。我们发现CGA-KO小鼠在A处出现高血压
年轻,但它逆转超过12个月的年龄。我们还注意到一些未使用的CGA-KO小鼠(全部
被搁置的男性)至少有40个月的生活。我们还发现脂蛋白脂肪酶的mRNA水平
(LPL)控制甘油三酸酯水平以及含4(VSIG4)的V-stet和免疫球蛋白结构域,它们
通过自噬的对照细菌清除率,CGA-KO幼鼠的心脏和肝脏较低,但很高
老鼠。我们进一步发现,细菌DNA泄漏到较老的WT小鼠中其他不同器官。这些
初步观察表明,CGA是老化引起的因素,但在早期起着积极的作用
通过维持脂质代谢而老化。我们建议将CGA的差分处理到CST
PST将通过调节代谢和注射涉及的因素来确定衰老。这
提案旨在通过评估寿命,生长,线粒体来研究我们假设的有效性
较大的WT和CGA-KO男性和女性的健康,能量消耗。我们将进一步
确定CGA诱导的衰老和涉及的途径至关重要的因素
CGA-KO小鼠的高血压和寿命延伸,重点是脂蛋白 - 磷灰胺
在四个不同组织中的儿茶酚胺 - 肾上腺素受体和VSIG-4-噬轴信号轴。
拟议的研究将由两位共同提议主持:生理学家Mahata博士的研究重点
关于高血压,胰岛素抵抗和免疫代谢,以及研究的生物化学家Ghosh博士
通过IKK-NF-B信号通路发出的炎症反应。如果假设被证明是正确的,
将进行长期研究以确定CGA诱导的衰老的潜在机制。
此处提出的实验还将有助于确定CGA是否可以针对治疗
通过降低CGA成绩单,炎症性疾病,与衰老有关的疾病和神经系统疾病
减少致病性影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GOURISANKAR GHOSH其他文献
GOURISANKAR GHOSH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GOURISANKAR GHOSH', 18)}}的其他基金
Suppressing Inflammation by Blocking IKK Oligomer
通过阻断 IKK 寡聚物抑制炎症
- 批准号:
10446098 - 财政年份:2022
- 资助金额:
$ 22.97万 - 项目类别:
Suppressing Inflammation by Blocking IKK Oligomer
通过阻断 IKK 寡聚物抑制炎症
- 批准号:
10573218 - 财政年份:2022
- 资助金额:
$ 22.97万 - 项目类别:
Investigation of Gene Regulation by NF-kappaB Transcription factors
NF-kappaB 转录因子基因调控的研究
- 批准号:
8260199 - 财政年份:2009
- 资助金额:
$ 22.97万 - 项目类别:
Investigation of gene regulation by NF-kappaB transcription factors
NF-κB转录因子基因调控的研究
- 批准号:
9021868 - 财政年份:2009
- 资助金额:
$ 22.97万 - 项目类别:
Investigation of gene regulation by NF-kappaB transcription factors
NF-κB转录因子基因调控的研究
- 批准号:
8904029 - 财政年份:2009
- 资助金额:
$ 22.97万 - 项目类别:
Cofactor-Mediated DNA Binding by the NF-kappaB Dimers
NF-kappaB 二聚体辅助因子介导的 DNA 结合
- 批准号:
9887959 - 财政年份:2009
- 资助金额:
$ 22.97万 - 项目类别:
相似国自然基金
内皮β3肾上腺素能受体调控线粒体功能参与血管衰老的作用研究
- 批准号:82370408
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
肾上腺素能受体激动剂引起睑板腺功能障碍发病的机制研究
- 批准号:82371024
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
心脏成纤维细胞β2-肾上腺素能受体对心衰小细胞外囊泡释放的作用机制研究
- 批准号:82370276
- 批准年份:2023
- 资助金额:47.00 万元
- 项目类别:面上项目
α1-和β3-肾上腺素能受体的荧光探针可视化研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
β2肾上腺素能受体调控皮肤角化细胞活化在慢性重叠型疼痛状态中的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Mechanisms of mitochondrial-ER communication during dietary and thermal induced stress
饮食和热应激期间线粒体-内质网通讯的机制
- 批准号:
10663603 - 财政年份:2023
- 资助金额:
$ 22.97万 - 项目类别:
Deciphering age-dependent beige adipocyte failure
解读年龄依赖性米色脂肪细胞衰竭
- 批准号:
10589822 - 财政年份:2022
- 资助金额:
$ 22.97万 - 项目类别:
Resistance Training Modulation of Fat Metabolism in Obese Postmenopausal Women
抗阻训练对肥胖绝经后妇女脂肪代谢的调节
- 批准号:
10383752 - 财政年份:2021
- 资助金额:
$ 22.97万 - 项目类别:
Trans-omic analysis of epicardial adipose tissue in atrial fibrillation
心房颤动心外膜脂肪组织的跨组学分析
- 批准号:
10330560 - 财政年份:2021
- 资助金额:
$ 22.97万 - 项目类别:
Resistance Training Modulation of Fat Metabolism in Obese Postmenopausal Women
抗阻训练对肥胖绝经后妇女脂肪代谢的调节
- 批准号:
10211863 - 财政年份:2021
- 资助金额:
$ 22.97万 - 项目类别: